Trial · NCT01468987
Adverse events336
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 336
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diabetic retinopathy | Eye disorders | LY2605541 + Insulin Lispro | 7 | 691 | 8 |
| other | Diabetic retinopathy | Eye disorders | Insulin Glargine + Insulin Lispro | 5 | 677 | 5 |
| other | Abdominal pain | Gastrointestinal disorders | LY2605541 + Insulin Lispro | 7 | 691 | 7 |
| other | Abdominal pain | Gastrointestinal disorders | Insulin Glargine + Insulin Lispro | 4 | 677 | 4 |
| other | Constipation | Gastrointestinal disorders | LY2605541 + Insulin Lispro | 9 | 691 | 9 |
| other | Constipation | Gastrointestinal disorders | Insulin Glargine + Insulin Lispro | 6 | 677 | 6 |
| other | Diarrhoea | Gastrointestinal disorders | LY2605541 + Insulin Lispro | 24 | 691 | 27 |
| other | Diarrhoea | Gastrointestinal disorders | Insulin Glargine + Insulin Lispro | 19 | 677 | 22 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | LY2605541 + Insulin Lispro | 7 | 691 | 7 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | Insulin Glargine + Insulin Lispro | 4 | 677 | 4 |
| other | Nausea | Gastrointestinal disorders | LY2605541 + Insulin Lispro | 16 | 691 | 16 |
| other | Nausea | Gastrointestinal disorders | Insulin Glargine + Insulin Lispro | 9 | 677 | 10 |
| other | Vomiting | Gastrointestinal disorders | LY2605541 + Insulin Lispro | 11 | 691 | 11 |
| other | Vomiting | Gastrointestinal disorders | Insulin Glargine + Insulin Lispro | 10 | 677 | 13 |
| other | Asthenia | General disorders | LY2605541 + Insulin Lispro | 0 | 691 | 0 |
| other | Asthenia | General disorders | Insulin Glargine + Insulin Lispro | 7 | 677 | 7 |
| other | Fatigue | General disorders | LY2605541 + Insulin Lispro | 6 | 691 | 8 |
| other | Fatigue | General disorders | Insulin Glargine + Insulin Lispro | 16 | 677 | 16 |
| other | Oedema peripheral | General disorders | LY2605541 + Insulin Lispro | 11 | 691 | 11 |
| other | Oedema peripheral | General disorders | Insulin Glargine + Insulin Lispro | 26 | 677 | 31 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01468987/events